These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12057715)

  • 1. Effects of the route of estrogen administration and exercise on hormonal levels in postmenopausal women.
    Williams CD; Dobridge JD; Meyer WR; Hackney AC
    Fertil Steril; 2002 Jun; 77(6):1118-24. PubMed ID: 12057715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
    Weissberger AJ; Ho KK; Lazarus L
    J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
    Bellantoni MF; Harman SM; Cho DE; Blackman MR
    J Clin Endocrinol Metab; 1991 Jan; 72(1):172-8. PubMed ID: 1824707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration route-dependent effects of estrogens on IGF-I levels during fixed GH replacement in women with hypopituitarism.
    van der Klaauw AA; Biermasz NR; Zelissen PM; Pereira AM; Lentjes EG; Smit JW; van Thiel SW; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2007 Dec; 157(6):709-16. PubMed ID: 18057377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
    Slater CC; Hodis HN; Mack WJ; Shoupe D; Paulson RJ; Stanczyk FZ
    Menopause; 2001; 8(3):200-3. PubMed ID: 11355042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
    Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study.
    Isotton AL; Wender MC; Casagrande A; Rollin G; Czepielewski MA
    Eur J Endocrinol; 2012 Feb; 166(2):207-13. PubMed ID: 22108915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of dose and route of estrogen administration on the somatotropic axis in normal women.
    Lissett CA; Shalet SM
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4668-72. PubMed ID: 14557438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY; Leung KC; Baxter RC; Ho KK
    J Clin Endocrinol Metab; 2000 May; 85(5):1918-22. PubMed ID: 10843175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A; Castelo-Branco C; Tarín JJ
    Fertil Steril; 1999 Feb; 71(2):261-7. PubMed ID: 9988395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women.
    Lindheim SR; Duffy DM; Kojima T; Vijod MA; Stanczyk FZ; Lobo RA
    Fertil Steril; 1994 Dec; 62(6):1176-80. PubMed ID: 7957980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT; Ross B; Anderson C; Archer DF
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol.
    Ginsburg ES; Walsh BW; Gao X; Gleason RE; Feltmate C; Barbieri RL
    J Soc Gynecol Investig; 1995; 2(1):26-9. PubMed ID: 9420845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.